A Core R&D Team Led by Industry Veterans and Overseas PhDs

Backed by industry-leading R&D investment, the company has built an internationalized research team with a distinguished academic profile. Nearly 70% of the team hold a Master’s degree or higher, with elite researchers—including PhDs and Post-doctoral fellows—accounting for nearly 20% of the workforce. This multi-tiered, cross-disciplinary, and highly synergistic R&D echelon provides a robust intellectual foundation for the company’s continuous technological innovation.


An Integrated Industry-Academia-Research Innovation Platform

The company has established strategic technical partnerships in veterinary vaccine development with numerous prestigious domestic and international research institutes and universities. These include the Lanzhou, Harbin, and Shanghai Veterinary Research Institutes of the Chinese Academy of Agricultural Sciences (CAAS), the Key Laboratory of Animal Immunology of the Ministry of Agriculture and Rural Affairs, as well as Shanghai Jiao Tong University, Henan Agricultural University, and Nanjing Agricultural University. Through a deeply integrated mechanism of industry-academia-research collaboration, we provide powerful support for the innovation of the company’s technologies and product pipelines.